BioCorRx Inc.
BioCorRx Inc. (BICX) Stock Competitors & Peer Comparison
See (BICX) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BICX | $0.35 | -7.39% | 7.3M | -2.19 | -$0.16 | N/A |
| FSNUY | $10.64 | -1.02% | 95.7B | 13.61 | $0.78 | +2.89% |
| FSNUF | $54.35 | +0.00% | 30.6B | 17.42 | $3.12 | +2.25% |
| JDHIF | $5.85 | +0.00% | 18.8B | 23.40 | $0.25 | N/A |
| JDHIY | $5.35 | +4.90% | 17.2B | 21.40 | $0.25 | N/A |
| IHHHF | $1.71 | +0.00% | 15.1B | 28.50 | $0.06 | +1.50% |
| FMCQF | $42.00 | +0.00% | 11.3B | 11.02 | $3.81 | +4.12% |
| BDUUF | $0.64 | +0.00% | 10.2B | 21.33 | $0.03 | +4.92% |
| BDUUY | $23.41 | +0.00% | 9.3B | 19.18 | $1.22 | +5.28% |
| BDULF | $0.56 | +0.00% | 8.9B | 18.67 | $0.03 | +5.63% |
Stock Comparison
BICX vs FSNUY Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, FSNUY has a market cap of 95.7B. Regarding current trading prices, BICX is priced at $0.35, while FSNUY trades at $10.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas FSNUY's P/E ratio is 13.61. In terms of profitability, BICX's ROE is +0.28%, compared to FSNUY's ROE of +0.08%. Regarding short-term risk, BICX is more volatile compared to FSNUY. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check FSNUY's competition here
BICX vs FSNUF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, FSNUF has a market cap of 30.6B. Regarding current trading prices, BICX is priced at $0.35, while FSNUF trades at $54.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas FSNUF's P/E ratio is 17.42. In terms of profitability, BICX's ROE is +0.28%, compared to FSNUF's ROE of +0.08%. Regarding short-term risk, BICX is more volatile compared to FSNUF. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check FSNUF's competition here
BICX vs JDHIF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, JDHIF has a market cap of 18.8B. Regarding current trading prices, BICX is priced at $0.35, while JDHIF trades at $5.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas JDHIF's P/E ratio is 23.40. In terms of profitability, BICX's ROE is +0.28%, compared to JDHIF's ROE of +0.09%. Regarding short-term risk, BICX is more volatile compared to JDHIF. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check JDHIF's competition here
BICX vs JDHIY Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, JDHIY has a market cap of 17.2B. Regarding current trading prices, BICX is priced at $0.35, while JDHIY trades at $5.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas JDHIY's P/E ratio is 21.40. In terms of profitability, BICX's ROE is +0.28%, compared to JDHIY's ROE of +0.09%. Regarding short-term risk, BICX is less volatile compared to JDHIY. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check JDHIY's competition here
BICX vs IHHHF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, IHHHF has a market cap of 15.1B. Regarding current trading prices, BICX is priced at $0.35, while IHHHF trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas IHHHF's P/E ratio is 28.50. In terms of profitability, BICX's ROE is +0.28%, compared to IHHHF's ROE of +0.07%. Regarding short-term risk, BICX is more volatile compared to IHHHF. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check IHHHF's competition here
BICX vs FMCQF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, FMCQF has a market cap of 11.3B. Regarding current trading prices, BICX is priced at $0.35, while FMCQF trades at $42.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas FMCQF's P/E ratio is 11.02. In terms of profitability, BICX's ROE is +0.28%, compared to FMCQF's ROE of +0.07%. Regarding short-term risk, BICX is more volatile compared to FMCQF. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check FMCQF's competition here
BICX vs BDUUF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, BDUUF has a market cap of 10.2B. Regarding current trading prices, BICX is priced at $0.35, while BDUUF trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas BDUUF's P/E ratio is 21.33. In terms of profitability, BICX's ROE is +0.28%, compared to BDUUF's ROE of +0.15%. Regarding short-term risk, BICX is less volatile compared to BDUUF. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check BDUUF's competition here
BICX vs BDUUY Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, BDUUY has a market cap of 9.3B. Regarding current trading prices, BICX is priced at $0.35, while BDUUY trades at $23.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas BDUUY's P/E ratio is 19.18. In terms of profitability, BICX's ROE is +0.28%, compared to BDUUY's ROE of +0.15%. Regarding short-term risk, BICX is less volatile compared to BDUUY. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check BDUUY's competition here
BICX vs BDULF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, BDULF has a market cap of 8.9B. Regarding current trading prices, BICX is priced at $0.35, while BDULF trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas BDULF's P/E ratio is 18.67. In terms of profitability, BICX's ROE is +0.28%, compared to BDULF's ROE of +0.15%. Regarding short-term risk, BICX is more volatile compared to BDULF. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check BDULF's competition here
BICX vs RMYHY Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, RMYHY has a market cap of 6.5B. Regarding current trading prices, BICX is priced at $0.35, while RMYHY trades at $7.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas RMYHY's P/E ratio is 30.96. In terms of profitability, BICX's ROE is +0.28%, compared to RMYHY's ROE of +0.06%. Regarding short-term risk, BICX is more volatile compared to RMYHY. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check RMYHY's competition here
BICX vs RMSYF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, RMSYF has a market cap of 5.7B. Regarding current trading prices, BICX is priced at $0.35, while RMSYF trades at $24.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas RMSYF's P/E ratio is 351.57. In terms of profitability, BICX's ROE is +0.28%, compared to RMSYF's ROE of +0.06%. Regarding short-term risk, BICX is more volatile compared to RMSYF. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check RMSYF's competition here
BICX vs BUHPF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, BUHPF has a market cap of 4.3B. Regarding current trading prices, BICX is priced at $0.35, while BUHPF trades at $5.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas BUHPF's P/E ratio is 20.96. In terms of profitability, BICX's ROE is +0.28%, compared to BUHPF's ROE of +0.25%. Regarding short-term risk, BICX is more volatile compared to BUHPF. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check BUHPF's competition here
BICX vs MCVEF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, MCVEF has a market cap of 4.1B. Regarding current trading prices, BICX is priced at $0.35, while MCVEF trades at $27.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas MCVEF's P/E ratio is 52.40. In terms of profitability, BICX's ROE is +0.28%, compared to MCVEF's ROE of +0.15%. Regarding short-term risk, BICX is less volatile compared to MCVEF. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check MCVEF's competition here
BICX vs ANHGY Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, ANHGY has a market cap of 4B. Regarding current trading prices, BICX is priced at $0.35, while ANHGY trades at $5.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas ANHGY's P/E ratio is 23.87. In terms of profitability, BICX's ROE is +0.28%, compared to ANHGY's ROE of N/A. Regarding short-term risk, BICX is more volatile compared to ANHGY. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check ANHGY's competition here
BICX vs BUGDF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, BUGDF has a market cap of 3.8B. Regarding current trading prices, BICX is priced at $0.35, while BUGDF trades at $4.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas BUGDF's P/E ratio is 16.96. In terms of profitability, BICX's ROE is +0.28%, compared to BUGDF's ROE of +0.25%. Regarding short-term risk, BICX is more volatile compared to BUGDF. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check BUGDF's competition here
BICX vs MCVEY Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, MCVEY has a market cap of 2.5B. Regarding current trading prices, BICX is priced at $0.35, while MCVEY trades at $16.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas MCVEY's P/E ratio is 40.37. In terms of profitability, BICX's ROE is +0.28%, compared to MCVEY's ROE of +0.16%. Regarding short-term risk, BICX is less volatile compared to MCVEY. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check MCVEY's competition here
BICX vs ORPEF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, ORPEF has a market cap of 2.3B. Regarding current trading prices, BICX is priced at $0.35, while ORPEF trades at $14.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas ORPEF's P/E ratio is 0.03. In terms of profitability, BICX's ROE is +0.28%, compared to ORPEF's ROE of -0.20%. Regarding short-term risk, BICX is less volatile compared to ORPEF. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check ORPEF's competition here
BICX vs EXETF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, EXETF has a market cap of 2.2B. Regarding current trading prices, BICX is priced at $0.35, while EXETF trades at $23.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas EXETF's P/E ratio is 23.83. In terms of profitability, BICX's ROE is +0.28%, compared to EXETF's ROE of +0.45%. Regarding short-term risk, BICX is more volatile compared to EXETF. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check EXETF's competition here
BICX vs LWSCF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, LWSCF has a market cap of 1.5B. Regarding current trading prices, BICX is priced at $0.35, while LWSCF trades at $15.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas LWSCF's P/E ratio is 43.94. In terms of profitability, BICX's ROE is +0.28%, compared to LWSCF's ROE of +0.06%. Regarding short-term risk, BICX is more volatile compared to LWSCF. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check LWSCF's competition here
BICX vs RAFLF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, RAFLF has a market cap of 1.5B. Regarding current trading prices, BICX is priced at $0.35, while RAFLF trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas RAFLF's P/E ratio is 26.67. In terms of profitability, BICX's ROE is +0.28%, compared to RAFLF's ROE of +0.05%. Regarding short-term risk, BICX is less volatile compared to RAFLF. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check RAFLF's competition here
BICX vs RHCGF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, RHCGF has a market cap of 1.4B. Regarding current trading prices, BICX is priced at $0.35, while RHCGF trades at $1.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas RHCGF's P/E ratio is -5.04. In terms of profitability, BICX's ROE is +0.28%, compared to RHCGF's ROE of -0.04%. Regarding short-term risk, BICX is less volatile compared to RHCGF. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check RHCGF's competition here
BICX vs RYHTY Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, RYHTY has a market cap of 1.2B. Regarding current trading prices, BICX is priced at $0.35, while RYHTY trades at $6.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas RYHTY's P/E ratio is -4.59. In terms of profitability, BICX's ROE is +0.28%, compared to RYHTY's ROE of -0.04%. Regarding short-term risk, BICX is more volatile compared to RYHTY. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check RYHTY's competition here
BICX vs LTGHF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, LTGHF has a market cap of 1.2B. Regarding current trading prices, BICX is priced at $0.35, while LTGHF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas LTGHF's P/E ratio is 13.58. In terms of profitability, BICX's ROE is +0.28%, compared to LTGHF's ROE of +7.19%. Regarding short-term risk, BICX is less volatile compared to LTGHF. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check LTGHF's competition here
BICX vs TTALF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, TTALF has a market cap of 1.1B. Regarding current trading prices, BICX is priced at $0.35, while TTALF trades at $8.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas TTALF's P/E ratio is 12.61. In terms of profitability, BICX's ROE is +0.28%, compared to TTALF's ROE of +0.14%. Regarding short-term risk, BICX is less volatile compared to TTALF. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check TTALF's competition here
BICX vs RKAGY Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, RKAGY has a market cap of 1.1B. Regarding current trading prices, BICX is priced at $0.35, while RKAGY trades at $8.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas RKAGY's P/E ratio is 24.73. In terms of profitability, BICX's ROE is +0.28%, compared to RKAGY's ROE of +0.03%. Regarding short-term risk, BICX is more volatile compared to RKAGY. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check RKAGY's competition here
BICX vs RHKJF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, RHKJF has a market cap of 1B. Regarding current trading prices, BICX is priced at $0.35, while RHKJF trades at $15.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas RHKJF's P/E ratio is 21.55. In terms of profitability, BICX's ROE is +0.28%, compared to RHKJF's ROE of +0.03%. Regarding short-term risk, BICX is more volatile compared to RHKJF. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check RHKJF's competition here
BICX vs LTGHY Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, LTGHY has a market cap of 930.7M. Regarding current trading prices, BICX is priced at $0.35, while LTGHY trades at $2.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas LTGHY's P/E ratio is -10.00. In terms of profitability, BICX's ROE is +0.28%, compared to LTGHY's ROE of +0.38%. Regarding short-term risk, BICX is less volatile compared to LTGHY. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check LTGHY's competition here
BICX vs NWKHY Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, NWKHY has a market cap of 871.6M. Regarding current trading prices, BICX is priced at $0.35, while NWKHY trades at $7.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas NWKHY's P/E ratio is 10.39. In terms of profitability, BICX's ROE is +0.28%, compared to NWKHY's ROE of +0.17%. Regarding short-term risk, BICX is more volatile compared to NWKHY. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check NWKHY's competition here
BICX vs WHTCF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, WHTCF has a market cap of 810.3M. Regarding current trading prices, BICX is priced at $0.35, while WHTCF trades at $3.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas WHTCF's P/E ratio is 39.65. In terms of profitability, BICX's ROE is +0.28%, compared to WHTCF's ROE of +0.03%. Regarding short-term risk, BICX is more volatile compared to WHTCF. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check WHTCF's competition here
BICX vs JXFGF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, JXFGF has a market cap of 755.4M. Regarding current trading prices, BICX is priced at $0.35, while JXFGF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas JXFGF's P/E ratio is -5.80. In terms of profitability, BICX's ROE is +0.28%, compared to JXFGF's ROE of -0.11%. Regarding short-term risk, BICX is less volatile compared to JXFGF. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check JXFGF's competition here
BICX vs KDGTF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, KDGTF has a market cap of 675.1M. Regarding current trading prices, BICX is priced at $0.35, while KDGTF trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas KDGTF's P/E ratio is -1.67. In terms of profitability, BICX's ROE is +0.28%, compared to KDGTF's ROE of N/A. Regarding short-term risk, BICX is more volatile compared to KDGTF. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check KDGTF's competition here
BICX vs WFHG Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, WFHG has a market cap of 476.9M. Regarding current trading prices, BICX is priced at $0.35, while WFHG trades at $7.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas WFHG's P/E ratio is N/A. In terms of profitability, BICX's ROE is +0.28%, compared to WFHG's ROE of +0.00%. Regarding short-term risk, BICX is more volatile compared to WFHG. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check WFHG's competition here
BICX vs ORRRY Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, ORRRY has a market cap of 371.5M. Regarding current trading prices, BICX is priced at $0.35, while ORRRY trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas ORRRY's P/E ratio is -0.33. In terms of profitability, BICX's ROE is +0.28%, compared to ORRRY's ROE of +7.04%. Regarding short-term risk, BICX is more volatile compared to ORRRY. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check ORRRY's competition here
BICX vs BTMDW Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, BTMDW has a market cap of 292.9M. Regarding current trading prices, BICX is priced at $0.35, while BTMDW trades at $1.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas BTMDW's P/E ratio is 0.05. In terms of profitability, BICX's ROE is +0.28%, compared to BTMDW's ROE of -0.23%. Regarding short-term risk, BICX is less volatile compared to BTMDW. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check BTMDW's competition here
BICX vs MFCSF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, MFCSF has a market cap of 222.2M. Regarding current trading prices, BICX is priced at $0.35, while MFCSF trades at $12.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas MFCSF's P/E ratio is 14.39. In terms of profitability, BICX's ROE is +0.28%, compared to MFCSF's ROE of +0.31%. Regarding short-term risk, BICX is more volatile compared to MFCSF. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check MFCSF's competition here
BICX vs MKLNF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, MKLNF has a market cap of 214.8M. Regarding current trading prices, BICX is priced at $0.35, while MKLNF trades at $11.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas MKLNF's P/E ratio is 19.23. In terms of profitability, BICX's ROE is +0.28%, compared to MKLNF's ROE of +0.19%. Regarding short-term risk, BICX is more volatile compared to MKLNF. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check MKLNF's competition here
BICX vs HWAIF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, HWAIF has a market cap of 193.9M. Regarding current trading prices, BICX is priced at $0.35, while HWAIF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas HWAIF's P/E ratio is -9.37. In terms of profitability, BICX's ROE is +0.28%, compared to HWAIF's ROE of -0.32%. Regarding short-term risk, BICX is less volatile compared to HWAIF. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check HWAIF's competition here
BICX vs CHHHF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, CHHHF has a market cap of 152.9M. Regarding current trading prices, BICX is priced at $0.35, while CHHHF trades at $2.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas CHHHF's P/E ratio is 7.77. In terms of profitability, BICX's ROE is +0.28%, compared to CHHHF's ROE of +0.27%. Regarding short-term risk, BICX is more volatile compared to CHHHF. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check CHHHF's competition here
BICX vs COLRF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, COLRF has a market cap of 123M. Regarding current trading prices, BICX is priced at $0.35, while COLRF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas COLRF's P/E ratio is -8.00. In terms of profitability, BICX's ROE is +0.28%, compared to COLRF's ROE of +0.00%. Regarding short-term risk, BICX is less volatile compared to COLRF. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check COLRF's competition here
BICX vs VTIAF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, VTIAF has a market cap of 111.1M. Regarding current trading prices, BICX is priced at $0.35, while VTIAF trades at $6.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas VTIAF's P/E ratio is -9.11. In terms of profitability, BICX's ROE is +0.28%, compared to VTIAF's ROE of -0.53%. Regarding short-term risk, BICX is more volatile compared to VTIAF. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check VTIAF's competition here
BICX vs TOKIF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, TOKIF has a market cap of 101.4M. Regarding current trading prices, BICX is priced at $0.35, while TOKIF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas TOKIF's P/E ratio is -0.57. In terms of profitability, BICX's ROE is +0.28%, compared to TOKIF's ROE of -0.83%. Regarding short-term risk, BICX is less volatile compared to TOKIF. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check TOKIF's competition here
BICX vs MCIOF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, MCIOF has a market cap of 54M. Regarding current trading prices, BICX is priced at $0.35, while MCIOF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas MCIOF's P/E ratio is -1.22. In terms of profitability, BICX's ROE is +0.28%, compared to MCIOF's ROE of N/A. Regarding short-term risk, BICX is more volatile compared to MCIOF. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check MCIOF's competition here
BICX vs NAFS Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, NAFS has a market cap of 49.1M. Regarding current trading prices, BICX is priced at $0.35, while NAFS trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas NAFS's P/E ratio is N/A. In terms of profitability, BICX's ROE is +0.28%, compared to NAFS's ROE of +0.31%. Regarding short-term risk, BICX is more volatile compared to NAFS. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check NAFS's competition here
BICX vs ASSF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, ASSF has a market cap of 45.3M. Regarding current trading prices, BICX is priced at $0.35, while ASSF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas ASSF's P/E ratio is -33.33. In terms of profitability, BICX's ROE is +0.28%, compared to ASSF's ROE of -6.63%. Regarding short-term risk, BICX is more volatile compared to ASSF. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check ASSF's competition here
BICX vs NVLPF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, NVLPF has a market cap of 24.7M. Regarding current trading prices, BICX is priced at $0.35, while NVLPF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas NVLPF's P/E ratio is 28.30. In terms of profitability, BICX's ROE is +0.28%, compared to NVLPF's ROE of +0.01%. Regarding short-term risk, BICX is more volatile compared to NVLPF. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check NVLPF's competition here
BICX vs USNU Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, USNU has a market cap of 22.2M. Regarding current trading prices, BICX is priced at $0.35, while USNU trades at $1.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas USNU's P/E ratio is -9.41. In terms of profitability, BICX's ROE is +0.28%, compared to USNU's ROE of -1.91%. Regarding short-term risk, BICX is less volatile compared to USNU. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check USNU's competition here
BICX vs HQDA Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, HQDA has a market cap of 18.6M. Regarding current trading prices, BICX is priced at $0.35, while HQDA trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas HQDA's P/E ratio is N/A. In terms of profitability, BICX's ROE is +0.28%, compared to HQDA's ROE of -0.06%. Regarding short-term risk, BICX is more volatile compared to HQDA. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check HQDA's competition here
BICX vs RHEPB Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, RHEPB has a market cap of 11.9M. Regarding current trading prices, BICX is priced at $0.35, while RHEPB trades at $6.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas RHEPB's P/E ratio is N/A. In terms of profitability, BICX's ROE is +0.28%, compared to RHEPB's ROE of +2.11%. Regarding short-term risk, BICX is less volatile compared to RHEPB. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check RHEPB's competition here
BICX vs FPCG Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, BICX is priced at $0.35, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas FPCG's P/E ratio is 0.09. In terms of profitability, BICX's ROE is +0.28%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, BICX is more volatile compared to FPCG. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check FPCG's competition here
BICX vs GBCS Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, GBCS has a market cap of 9.1M. Regarding current trading prices, BICX is priced at $0.35, while GBCS trades at $2.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas GBCS's P/E ratio is 1.67. In terms of profitability, BICX's ROE is +0.28%, compared to GBCS's ROE of -1.37%. Regarding short-term risk, BICX is less volatile compared to GBCS. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check GBCS's competition here
BICX vs NUMIF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, NUMIF has a market cap of 7.4M. Regarding current trading prices, BICX is priced at $0.35, while NUMIF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas NUMIF's P/E ratio is -0.77. In terms of profitability, BICX's ROE is +0.28%, compared to NUMIF's ROE of +11.51%. Regarding short-term risk, BICX is less volatile compared to NUMIF. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check NUMIF's competition here
BICX vs HLYK Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, HLYK has a market cap of 6.7M. Regarding current trading prices, BICX is priced at $0.35, while HLYK trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas HLYK's P/E ratio is -1.69. In terms of profitability, BICX's ROE is +0.28%, compared to HLYK's ROE of +0.67%. Regarding short-term risk, BICX is more volatile compared to HLYK. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check HLYK's competition here
BICX vs MAHN Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, MAHN has a market cap of 6.1M. Regarding current trading prices, BICX is priced at $0.35, while MAHN trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas MAHN's P/E ratio is 250.00. In terms of profitability, BICX's ROE is +0.28%, compared to MAHN's ROE of N/A. Regarding short-term risk, BICX is less volatile compared to MAHN. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check MAHN's competition here
BICX vs RVLWF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, RVLWF has a market cap of 5.4M. Regarding current trading prices, BICX is priced at $0.35, while RVLWF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas RVLWF's P/E ratio is -0.30. In terms of profitability, BICX's ROE is +0.28%, compared to RVLWF's ROE of +3.95%. Regarding short-term risk, BICX is more volatile compared to RVLWF. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check RVLWF's competition here
BICX vs JRSS Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, JRSS has a market cap of 5.1M. Regarding current trading prices, BICX is priced at $0.35, while JRSS trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas JRSS's P/E ratio is -0.17. In terms of profitability, BICX's ROE is +0.28%, compared to JRSS's ROE of -0.07%. Regarding short-term risk, BICX is less volatile compared to JRSS. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check JRSS's competition here
BICX vs XCRT Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, XCRT has a market cap of 4.2M. Regarding current trading prices, BICX is priced at $0.35, while XCRT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas XCRT's P/E ratio is N/A. In terms of profitability, BICX's ROE is +0.28%, compared to XCRT's ROE of +0.70%. Regarding short-term risk, BICX is less volatile compared to XCRT. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check XCRT's competition here
BICX vs VLXC Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, VLXC has a market cap of 3.2M. Regarding current trading prices, BICX is priced at $0.35, while VLXC trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas VLXC's P/E ratio is -3.25. In terms of profitability, BICX's ROE is +0.28%, compared to VLXC's ROE of +0.74%. Regarding short-term risk, BICX is less volatile compared to VLXC. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check VLXC's competition here
BICX vs RHEP Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, RHEP has a market cap of 2.6M. Regarding current trading prices, BICX is priced at $0.35, while RHEP trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas RHEP's P/E ratio is 0.66. In terms of profitability, BICX's ROE is +0.28%, compared to RHEP's ROE of +2.11%. Regarding short-term risk, BICX is less volatile compared to RHEP. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check RHEP's competition here
BICX vs EPWCF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, EPWCF has a market cap of 2.5M. Regarding current trading prices, BICX is priced at $0.35, while EPWCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas EPWCF's P/E ratio is -0.00. In terms of profitability, BICX's ROE is +0.28%, compared to EPWCF's ROE of +0.00%. Regarding short-term risk, BICX is less volatile compared to EPWCF. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check EPWCF's competition here
BICX vs EVGRF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, EVGRF has a market cap of 2.2M. Regarding current trading prices, BICX is priced at $0.35, while EVGRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas EVGRF's P/E ratio is N/A. In terms of profitability, BICX's ROE is +0.28%, compared to EVGRF's ROE of +0.22%. Regarding short-term risk, BICX is less volatile compared to EVGRF. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check EVGRF's competition here
BICX vs NRPR Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, NRPR has a market cap of 2.1M. Regarding current trading prices, BICX is priced at $0.35, while NRPR trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas NRPR's P/E ratio is -0.03. In terms of profitability, BICX's ROE is +0.28%, compared to NRPR's ROE of N/A. Regarding short-term risk, BICX is more volatile compared to NRPR. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check NRPR's competition here
BICX vs KJFI Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, KJFI has a market cap of 2.1M. Regarding current trading prices, BICX is priced at $0.35, while KJFI trades at $0.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas KJFI's P/E ratio is -0.06. In terms of profitability, BICX's ROE is +0.28%, compared to KJFI's ROE of +0.00%. Regarding short-term risk, BICX is more volatile compared to KJFI. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check KJFI's competition here
BICX vs SMAS Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, SMAS has a market cap of 1.5M. Regarding current trading prices, BICX is priced at $0.35, while SMAS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas SMAS's P/E ratio is N/A. In terms of profitability, BICX's ROE is +0.28%, compared to SMAS's ROE of N/A. Regarding short-term risk, BICX is less volatile compared to SMAS. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check SMAS's competition here
BICX vs MDGP Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, MDGP has a market cap of 1.5M. Regarding current trading prices, BICX is priced at $0.35, while MDGP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas MDGP's P/E ratio is N/A. In terms of profitability, BICX's ROE is +0.28%, compared to MDGP's ROE of -2.19%. Regarding short-term risk, BICX is more volatile compared to MDGP. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check MDGP's competition here
BICX vs NOVC Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, NOVC has a market cap of 1.2M. Regarding current trading prices, BICX is priced at $0.35, while NOVC trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas NOVC's P/E ratio is -0.20. In terms of profitability, BICX's ROE is +0.28%, compared to NOVC's ROE of +0.12%. Regarding short-term risk, BICX is more volatile compared to NOVC. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check NOVC's competition here
BICX vs DPAT Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, DPAT has a market cap of 1.1M. Regarding current trading prices, BICX is priced at $0.35, while DPAT trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas DPAT's P/E ratio is -2.25. In terms of profitability, BICX's ROE is +0.28%, compared to DPAT's ROE of +0.59%. Regarding short-term risk, BICX is more volatile compared to DPAT. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check DPAT's competition here
BICX vs PHMB Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, PHMB has a market cap of 1.1M. Regarding current trading prices, BICX is priced at $0.35, while PHMB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas PHMB's P/E ratio is N/A. In terms of profitability, BICX's ROE is +0.28%, compared to PHMB's ROE of N/A. Regarding short-term risk, BICX is less volatile compared to PHMB. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check PHMB's competition here
BICX vs GNOW Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, GNOW has a market cap of 859.7K. Regarding current trading prices, BICX is priced at $0.35, while GNOW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas GNOW's P/E ratio is -0.01. In terms of profitability, BICX's ROE is +0.28%, compared to GNOW's ROE of -12.49%. Regarding short-term risk, BICX is more volatile compared to GNOW. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check GNOW's competition here
BICX vs JNHMF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, JNHMF has a market cap of 779.5K. Regarding current trading prices, BICX is priced at $0.35, while JNHMF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas JNHMF's P/E ratio is -0.01. In terms of profitability, BICX's ROE is +0.28%, compared to JNHMF's ROE of -101.83%. Regarding short-term risk, BICX is more volatile compared to JNHMF. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check JNHMF's competition here
BICX vs GRST Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, GRST has a market cap of 772.6K. Regarding current trading prices, BICX is priced at $0.35, while GRST trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas GRST's P/E ratio is N/A. In terms of profitability, BICX's ROE is +0.28%, compared to GRST's ROE of +0.17%. Regarding short-term risk, BICX is more volatile compared to GRST. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check GRST's competition here
BICX vs MSITF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, MSITF has a market cap of 480K. Regarding current trading prices, BICX is priced at $0.35, while MSITF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas MSITF's P/E ratio is -0.10. In terms of profitability, BICX's ROE is +0.28%, compared to MSITF's ROE of N/A. Regarding short-term risk, BICX is less volatile compared to MSITF. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check MSITF's competition here
BICX vs ARPC Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, ARPC has a market cap of 336.6K. Regarding current trading prices, BICX is priced at $0.35, while ARPC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas ARPC's P/E ratio is N/A. In terms of profitability, BICX's ROE is +0.28%, compared to ARPC's ROE of +3.10%. Regarding short-term risk, BICX is less volatile compared to ARPC. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check ARPC's competition here
BICX vs NXGT Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, NXGT has a market cap of 288.5K. Regarding current trading prices, BICX is priced at $0.35, while NXGT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas NXGT's P/E ratio is N/A. In terms of profitability, BICX's ROE is +0.28%, compared to NXGT's ROE of +0.03%. Regarding short-term risk, BICX is more volatile compared to NXGT. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check NXGT's competition here
BICX vs BNYN Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, BNYN has a market cap of 286K. Regarding current trading prices, BICX is priced at $0.35, while BNYN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas BNYN's P/E ratio is N/A. In terms of profitability, BICX's ROE is +0.28%, compared to BNYN's ROE of -14.10%. Regarding short-term risk, BICX is less volatile compared to BNYN. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check BNYN's competition here
BICX vs SETO Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, SETO has a market cap of 137.2K. Regarding current trading prices, BICX is priced at $0.35, while SETO trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas SETO's P/E ratio is -1.10. In terms of profitability, BICX's ROE is +0.28%, compared to SETO's ROE of -0.15%. Regarding short-term risk, BICX is more volatile compared to SETO. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check SETO's competition here
BICX vs FCHS Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, FCHS has a market cap of 131.8K. Regarding current trading prices, BICX is priced at $0.35, while FCHS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas FCHS's P/E ratio is -0.02. In terms of profitability, BICX's ROE is +0.28%, compared to FCHS's ROE of +0.19%. Regarding short-term risk, BICX is less volatile compared to FCHS. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check FCHS's competition here
BICX vs TPIA Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, TPIA has a market cap of 113.8K. Regarding current trading prices, BICX is priced at $0.35, while TPIA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas TPIA's P/E ratio is -0.15. In terms of profitability, BICX's ROE is +0.28%, compared to TPIA's ROE of +0.56%. Regarding short-term risk, BICX is less volatile compared to TPIA. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check TPIA's competition here
BICX vs AMBD Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, AMBD has a market cap of 85.6K. Regarding current trading prices, BICX is priced at $0.35, while AMBD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas AMBD's P/E ratio is N/A. In terms of profitability, BICX's ROE is +0.28%, compared to AMBD's ROE of +1.11%. Regarding short-term risk, BICX is less volatile compared to AMBD. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check AMBD's competition here
BICX vs NMHLY Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, NMHLY has a market cap of 41.7K. Regarding current trading prices, BICX is priced at $0.35, while NMHLY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas NMHLY's P/E ratio is 0.02. In terms of profitability, BICX's ROE is +0.28%, compared to NMHLY's ROE of N/A. Regarding short-term risk, BICX is more volatile compared to NMHLY. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check NMHLY's competition here
BICX vs MSGP Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, MSGP has a market cap of 31.1K. Regarding current trading prices, BICX is priced at $0.35, while MSGP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas MSGP's P/E ratio is N/A. In terms of profitability, BICX's ROE is +0.28%, compared to MSGP's ROE of +0.27%. Regarding short-term risk, BICX is less volatile compared to MSGP. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check MSGP's competition here
BICX vs DRWN Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, DRWN has a market cap of 24K. Regarding current trading prices, BICX is priced at $0.35, while DRWN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas DRWN's P/E ratio is N/A. In terms of profitability, BICX's ROE is +0.28%, compared to DRWN's ROE of -0.01%. Regarding short-term risk, BICX is less volatile compared to DRWN. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check DRWN's competition here
BICX vs PRMD Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, PRMD has a market cap of 20.3K. Regarding current trading prices, BICX is priced at $0.35, while PRMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas PRMD's P/E ratio is N/A. In terms of profitability, BICX's ROE is +0.28%, compared to PRMD's ROE of +0.73%. Regarding short-term risk, BICX is less volatile compared to PRMD. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check PRMD's competition here
BICX vs HSMD Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, HSMD has a market cap of 18.4K. Regarding current trading prices, BICX is priced at $0.35, while HSMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas HSMD's P/E ratio is -0.01. In terms of profitability, BICX's ROE is +0.28%, compared to HSMD's ROE of -0.04%. Regarding short-term risk, BICX is more volatile compared to HSMD. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check HSMD's competition here
BICX vs SCAL Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, SCAL has a market cap of 17.4K. Regarding current trading prices, BICX is priced at $0.35, while SCAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas SCAL's P/E ratio is 0.04. In terms of profitability, BICX's ROE is +0.28%, compared to SCAL's ROE of +0.07%. Regarding short-term risk, BICX is more volatile compared to SCAL. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check SCAL's competition here
BICX vs GENN Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, GENN has a market cap of 12.1K. Regarding current trading prices, BICX is priced at $0.35, while GENN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas GENN's P/E ratio is -0.01. In terms of profitability, BICX's ROE is +0.28%, compared to GENN's ROE of +0.07%. Regarding short-term risk, BICX is less volatile compared to GENN. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check GENN's competition here
BICX vs CHCR Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, CHCR has a market cap of 12K. Regarding current trading prices, BICX is priced at $0.35, while CHCR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas CHCR's P/E ratio is -0.00. In terms of profitability, BICX's ROE is +0.28%, compared to CHCR's ROE of N/A. Regarding short-term risk, BICX is more volatile compared to CHCR. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check CHCR's competition here
BICX vs ACGI Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, ACGI has a market cap of 10.5K. Regarding current trading prices, BICX is priced at $0.35, while ACGI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas ACGI's P/E ratio is N/A. In terms of profitability, BICX's ROE is +0.28%, compared to ACGI's ROE of +1.11%. Regarding short-term risk, BICX is less volatile compared to ACGI. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check ACGI's competition here
BICX vs CLRD Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, CLRD has a market cap of 10.5K. Regarding current trading prices, BICX is priced at $0.35, while CLRD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas CLRD's P/E ratio is N/A. In terms of profitability, BICX's ROE is +0.28%, compared to CLRD's ROE of +0.38%. Regarding short-term risk, BICX is less volatile compared to CLRD. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check CLRD's competition here
BICX vs CEVE Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, CEVE has a market cap of 8.6K. Regarding current trading prices, BICX is priced at $0.35, while CEVE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas CEVE's P/E ratio is N/A. In terms of profitability, BICX's ROE is +0.28%, compared to CEVE's ROE of +2.26%. Regarding short-term risk, BICX is less volatile compared to CEVE. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check CEVE's competition here
BICX vs PAOG Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, PAOG has a market cap of 7.4K. Regarding current trading prices, BICX is priced at $0.35, while PAOG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas PAOG's P/E ratio is N/A. In terms of profitability, BICX's ROE is +0.28%, compared to PAOG's ROE of +0.03%. Regarding short-term risk, BICX is less volatile compared to PAOG. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check PAOG's competition here
BICX vs WEQL Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, WEQL has a market cap of 7.2K. Regarding current trading prices, BICX is priced at $0.35, while WEQL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas WEQL's P/E ratio is N/A. In terms of profitability, BICX's ROE is +0.28%, compared to WEQL's ROE of +0.21%. Regarding short-term risk, BICX is less volatile compared to WEQL. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check WEQL's competition here
BICX vs SLHGF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, SLHGF has a market cap of 4K. Regarding current trading prices, BICX is priced at $0.35, while SLHGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas SLHGF's P/E ratio is N/A. In terms of profitability, BICX's ROE is +0.28%, compared to SLHGF's ROE of -0.42%. Regarding short-term risk, BICX is less volatile compared to SLHGF. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check SLHGF's competition here
BICX vs SLHPF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, SLHPF has a market cap of 3.9K. Regarding current trading prices, BICX is priced at $0.35, while SLHPF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas SLHPF's P/E ratio is N/A. In terms of profitability, BICX's ROE is +0.28%, compared to SLHPF's ROE of -0.42%. Regarding short-term risk, BICX is less volatile compared to SLHPF. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check SLHPF's competition here
BICX vs ERUC Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, ERUC has a market cap of 3.9K. Regarding current trading prices, BICX is priced at $0.35, while ERUC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas ERUC's P/E ratio is N/A. In terms of profitability, BICX's ROE is +0.28%, compared to ERUC's ROE of N/A. Regarding short-term risk, BICX is more volatile compared to ERUC. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check ERUC's competition here
BICX vs BBAL Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, BBAL has a market cap of 3.4K. Regarding current trading prices, BICX is priced at $0.35, while BBAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas BBAL's P/E ratio is N/A. In terms of profitability, BICX's ROE is +0.28%, compared to BBAL's ROE of +0.45%. Regarding short-term risk, BICX is more volatile compared to BBAL. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check BBAL's competition here
BICX vs NMMCF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, NMMCF has a market cap of 2.1K. Regarding current trading prices, BICX is priced at $0.35, while NMMCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas NMMCF's P/E ratio is 0.00. In terms of profitability, BICX's ROE is +0.28%, compared to NMMCF's ROE of +0.21%. Regarding short-term risk, BICX is more volatile compared to NMMCF. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check NMMCF's competition here
BICX vs PPRG Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, PPRG has a market cap of 1.6K. Regarding current trading prices, BICX is priced at $0.35, while PPRG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas PPRG's P/E ratio is N/A. In terms of profitability, BICX's ROE is +0.28%, compared to PPRG's ROE of -0.58%. Regarding short-term risk, BICX is more volatile compared to PPRG. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check PPRG's competition here
BICX vs KONEF Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, KONEF has a market cap of 1.6K. Regarding current trading prices, BICX is priced at $0.35, while KONEF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas KONEF's P/E ratio is N/A. In terms of profitability, BICX's ROE is +0.28%, compared to KONEF's ROE of -6.56%. Regarding short-term risk, BICX is less volatile compared to KONEF. This indicates potentially lower risk in terms of short-term price fluctuations for BICX.Check KONEF's competition here
BICX vs OHAQ Comparison May 2026
BICX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BICX stands at 7.3M. In comparison, OHAQ has a market cap of 1.4K. Regarding current trading prices, BICX is priced at $0.35, while OHAQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BICX currently has a P/E ratio of -2.19, whereas OHAQ's P/E ratio is 0.01. In terms of profitability, BICX's ROE is +0.28%, compared to OHAQ's ROE of +0.09%. Regarding short-term risk, BICX is more volatile compared to OHAQ. This indicates potentially higher risk in terms of short-term price fluctuations for BICX.Check OHAQ's competition here